Prostate cancer and prostatic diseases
Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.
Jennifer Le Guevelou, Thomas Zilli, Federica Ferrario, Vedang Murthy, Alison Tree, Andrew Loblaw, Uulke A Van der Heide, Amar Kishan, Cédric Draulans, Jarad Martin, Piet Ost, Paul Sargos
Published: 202510.1038/s41391-025-01071-7
Abstract
BACKGROUND: The technical advances allowed to take the leap towards hypofractionated schedules, as well as dose-escalated schedules, for prostate cancer (PCa) radiotherapy (RT). The aim of this systematic review is to describe RT techniques and toxic…
Preview only. Read the full abstract at the source